Hospital Universitario Quiron Dexeus
Barcelona, 08028, Spain
NCT Number: NCT04880590
This study aims to evaluate the impact of sexual intercourse and orgasm in the 72 hrs following embryo transfer of blastocysts on the clinical pregnancy rate.
An impact on sexual activity and a decrease in the frequency of intercourse has been observed in infertile couples. In couples who undergo assisted reproductive technology (ART), sexual relations have an additional component that can condition them, such as the fear of influencing the outcome of the cycle.
The usual practice in ART cycles has evolved towards a preference for blastocyst-stage embryo transfer, both in fresh in vitro fertilization (IVF) cycles and in frozen embryo transfer (FET) cycles.
The investigators consider it important to elucidate whether coital intercourse after embryo transfer (ET) has an impact on the clinical pregnancy rate after the transfer of blastocyst-stage embryos.
Looking for future studies?
Notify MeFemale
Observational
Barcelona, 08028, Spain
It is proposed to carry out an observational, prospective study, in which women with a heterosexual sexual relationship are included, who carry out an embryo transfer, in a FET cycle in the Dexeus Woman Reproduction Medicine Service and who agree to participate in the same.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A heterosexual sexual relationship
Time frame: 6-7 weeks after transfer
Clinical pregnancy rate measured by ultrasound with the presence of a positive fetal heartbeat
Time frame: Until 13 weeks after embryo transfer procedure
The loss of a pregnancy during the first 13 weeks of pregnancy
Time frame: Until 42 weeks after embryo transfer
Number of live birth after embryo transfer
Fundación Santiago Dexeus Font
Other
Sex or no Sex: That is the Question. Impact of Coital Sexual Intercourse on the Clinical Pregnancy Rate After Embryo Transfer.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06206746
Adnexal Diseases, Cysts
Encino, California, United States
View Trial DetailsNCT07810920
Adenomyosis, Adenomyosis of Uterus
Budapest, Hungary
View Trial DetailsNCT06635538
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Sabadell, Barcelona, Spain
View Trial DetailsNCT07409792
Anxiety, Anxiety Disorders
Hangzhou, Zhejiang, China
View Trial Details